LFCR · Lifecore Biomedical Inc
United States · RS rating 84 · As of 2026-10-14
| Price | 6.42 USD |
|---|---|
| 1-day change | +0.0% |
| RS rating (overall / 1M / 3M / 12M) | 84 / 98 / 93 / 40 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 31 / 33 / 38 |
| Industry group (rank) | Medical-Ethical Drugs (91) |
| EPS growth Q/Q | -383.3% |
| Sales growth Q/Q | -14.6% |
| Distance from 52-week high | +27.2% |
| Market cap (USD) | $184.4M |